Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elis M&A Activity 2019

Jul 8, 2019

1280_iss_2019-07-08_be898f82-a827-4c98-ae18-85177bb65907.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Elis announces the divestment of the Single Use/Medical Consumables (Rocialle/Guardian) division of Clinical Solutions in the UK

Saint-Cloud, July 8, 2019 – Elis, an international multi-service provider, offering textile, hygiene and facility services solutions across Europe and Latin America, announces it has signed an agreement to divest of 100% of the Single Use (Rocialle) / Medical Consumables (Guardian)division of Clinical Solutions in the UK. The closing of the transaction is subject to certain legal and regulatory conditions and is expected to take place by the end of Q3 2019.

"Single Use (Rocialle) / Medical Consumables (Guardian)" is one of the two divisions of Clinical Solutions that were formerly owned by Berendsen until its acquisition by Elis in 2017. This division provides customised procedure trays, medical procedure packs that contain consumable items required for specific surgery, and branded medical drapes, gowns and surgical tray wraps.

This activity, based in the UK, posted revenues of c. £42mn in 2018.

In H1 2018, in a step to remain focused on its core business, Elis announced its intention to sell Clinical Solutions in a two-stage process. IHSS the "Decontamination and Sterilization Services" division still remains to be sold.

Contacts Nicolas Buron Investor Relations Director – Phone: +33 1 75 49 98 30 - [email protected]

Audrey Bourgeois Investor Relations – Phone: +33 1 75 49 96 25 - [email protected]